Cardinal Health Given New $78.50 Price Target at ISI Group (CAH)
Analysts at ISI Group lifted their target price on shares of Cardinal Health (NYSE:CAH) from $77.00 to $78.50 in a research report issued to clients and investors on Monday. The firm currently has a “buy” rating on the stock. ISI Group’s target price indicates a potential upside of 8.47% from the company’s current price.
A number of other analysts have also recently weighed in on CAH. Analysts at Robert W. Baird raised their price target on shares of Cardinal Health from $80.00 to $82.00 in a research note on Wednesday, July 9th. Separately, analysts at Zacks downgraded shares of Cardinal Health from an “outperform” rating to a “neutral” rating in a research note on Wednesday, June 11th. They now have a $74.00 price target on the stock. Finally, analysts at Morgan Stanley reiterated an “overweight” rating on shares of Cardinal Health in a research note on Monday, June 2nd. They now have a $76.00 price target on the stock. Three analysts have rated the stock with a hold rating and ten have given a buy rating to the company. Cardinal Health currently has an average rating of “Buy” and an average target price of $76.84.
In other Cardinal Health news, CAO Stuart G. Laws sold 21,266 shares of Cardinal Health stock on the open market in a transaction that occurred on Thursday, July 24th. The stock was sold at an average price of $72.50, for a total transaction of $1,541,785.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
Shares of Cardinal Health (NYSE:CAH) traded down 4.39% on Monday, hitting $69.19. 3,116,576 shares of the company’s stock traded hands. Cardinal Health has a 52-week low of $49.65 and a 52-week high of $74.40. The stock has a 50-day moving average of $70.22 and a 200-day moving average of $69.24. The company has a market cap of $23.539 billion and a P/E ratio of 72.37.
Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Monday, August 4th. The company reported $0.83 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.81 by $0.02. The company had revenue of $2.90 billion for the quarter, compared to the consensus estimate of $21.88 billion. During the same quarter in the prior year, the company posted $0.79 earnings per share. The company’s quarterly revenue was down 9.9% on a year-over-year basis. On average, analysts predict that Cardinal Health will post $3.82 earnings per share for the current fiscal year.
Cardinal Health, Inc is a healthcare services company providing pharmaceutical and medical products and services to pharmacies, hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.
Receive News & Ratings for Cardinal Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.